| answer text |
<p>Cladribine is not licensed for the treatment of multiple sclerosis.</p><p><strong>
</strong></p><p>Prescribers can prescribe a medicine “off label” for unlicensed indications
if they consider it to be of benefit to the patient and on condition that they retain
full clinical responsibility for that patient.</p><p> </p><p>The National Institute
for Health Research Horizon Scanning Centre published a report on cladribine for multiple
sclerosis in 2008 and this is available at:</p><p> </p><p>www.hsc.nihr.ac.uk/topics/cladribine-movectro-for-multiple-sclerosis-relapsi</p><p>
</p><p>We have made no assessment of research undertaken in other countries.</p><p>
</p>
|
 |
